Acquired microsatellite instability status and loss of HER2 positivity during treatment of gastro-esophageal junction adenocarcinoma.

Alexis, Lynn Gabrielle;Dano, Hélène;Dekairelle, Anne-France;van Marcke de Lummen, Cedric Jacques;Van den Eynde, Marc
(2023) Digestive and Liver Disease — Vol. 55, n° 3, p. 426-428 (2023)

Files

1-s20-S1590865822008210-main.pdf
  • Open Access
  • Adobe PDF
  • 1.02 MB
Download

Details

Authors
Abstract
(en) DEAR EDITOR, Gastro-oesophageal adenocarcinomas (GOAs) are a common cause of cancer mortality worldwide. Nowadays, beyond histological classification, the management of GOAs depends on molecular classification. The Cancer Genome Atlas consortium identified four different molecular subtypes of GOAs potentially allowing to tailor the treatment strategies [...].
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Alexis, L. G., Dano, H., Dekairelle, A.-F., van Marcke de Lummen, C. J., & Van den Eynde, M. (2023). Acquired microsatellite instability status and loss of HER2 positivity during treatment of gastro-esophageal junction adenocarcinoma. Digestive and Liver Disease, 55(3), 426-428. https://doi.org/10.1016/j.dld.2022.11.023 (Original work published 2023)